Breathing disorders in Prader-Willi syndrome: The role of obesity, growth hormone treatment and upper respiratory tract infections

Expert Review of Endocrinology and Metabolism

Volumn 2, Issue 4, 2007, Pages 529-537

  Festen, Dederieke A M ^a   Hokken Koelega, Anita C S ^b  

^a Dutch Growth Foundation   (Netherlands)

^b SOPHIA CHILDREN S HOSPITAL   (Netherlands)

Author keywords

Breathing; Growth hormone; Polysomnography; Prader Willi syndrome

Indexed keywords

ACETAZOLAMIDE; BRONCHODILATING AGENT; GROWTH HORMONE; MEDROXYPROGESTERONE; PLACEBO; THEOPHYLLINE;

ADENOIDECTOMY; BEHAVIOR DISORDER; BODY MASS; BREATHING DISORDER; BREATHING MECHANICS; CENTRAL SLEEP APNEA SYNDROME; CLINICAL ASSESSMENT; CLINICAL FEATURE; CLINICAL TRIAL; COGNITIVE DEFECT; COMORBIDITY; COR PULMONALE; DAYTIME SOMNOLENCE; DISEASE ASSOCIATION; DISEASE COURSE; DISEASE SEVERITY; HEART VENTRICLE HYPERTROPHY; HIGH RISK PATIENT; HUMAN; HYPERCAPNIA; HYPERTENSION; HYPOVENTILATION; HYPOXIA; KYPHOSCOLIOSIS; NONHUMAN; OBESITY; OXYGEN SATURATION; PATHOPHYSIOLOGY; PATIENT MONITORING; POLYSOMNOGRAPHY; POSITIVE END EXPIRATORY PRESSURE; PRADER WILLI SYNDROME; PRIORITY JOURNAL; REVIEW; RISK ASSESSMENT; RISK FACTOR; SIDE EFFECT; SLEEP APNEA SYNDROME; SLEEP AROUSAL DISORDER; SLEEP PATTERN; SODIUM RETENTION; TONSIL DISEASE; TREATMENT DURATION; UPPER RESPIRATORY TRACT INFECTION; WAKEFULNESS;

EID: 34547511493     PISSN: 17446651     EISSN: None     Source Type: Journal    
DOI: 10.1586/17446651.2.4.529     Document Type: Review

References (74)

1. Prader A, Labhart A, Willi H. Ein Syndrom von adipositas, kleinwuchs, kryptorchidismus und oligophrenie nach myatonieartigem zustand im neugeborenalter. Schweiz. Med. Wschr. 86, 1269-1261 (1956).
2. Holm V, Cassidy S, Butler M et al. Prader-Willi syndrome: consensus diagnostic criteria. Pediatrics 9l, 398-340 (1993).
3. Ledbetter D, Riccardi V, Aihart S, Strobel R, Keenan S, Crawford J. Deletions of chromosome 15 as a cause of the Prader-Willi syndrome. N. Engl. J. Med. 304, 325-329 (1981).
4. Butler M, Palmer C. Parental origin of chromosome 15 deletion in Prader-Willi syndrome. Lancet 1285-1286 (1983).
5. Nicholls R, Knoll J, Butler M, Karam S, Lalande M. Genetic imprinting suggested by maternal heterodisomy in non-deletion Prader-Willi syndrome. Nature 342. 281-284 (1989).
6. Reis A, Dittrich B, Greger V et al. Imprinting mutations suggested by abnormal DNA methylation patterns in familial Angelman and Prader-Willi syndromes. Am. J. Hum. Genet. 54, 741-747 (1994).
7. Sutcliffe J, Nakao M, Christian S et al. Deletions of a differentially methylated CpG island at the SNRPN gene define a putative imprinting control region. Nat. Genet. 8, 52-58 (1994).
8. Swaab D. Prader-Willi and the hypothalamus. Acta Paediatr. 423(Suppl.), 50-54 (1997).
9. Dittrich B, Robinson W, Knoblauch H et al. Molecular diagnosis of the Prader-Willl and Angelman syndromes by detection of parent-of-origin specific DNA methylation in 15q 11- 13. Hum. Genet. 90, 313-315 (1992).
10. Richards A, Quaghebeur G, Clift S, Holland A, Dahlitz M, Parkes D. The upper airway and sleep apnoea in the Prader-Willi syndrome. Clin. Otolaryngol. Allied Sci. 19, 193-197 (1994).
11. Hakonarson H, Moskovitz J, Daigle K, Cassidy S, Cloutier M. Pulmonary function abnormalities in Prader Willi Syndrome. J. Pediatr. 126, 565-570 (1995).
12. Nixon G, Brouillete R. Sleep and breathing in Prader Willi Syndrome. Pediatr. Pulmonol. 34, 209-217 (2002).
13. Eiholzer U. Deaths in children with Prader-Willi syndrome. Horm. Res. 63, 33-39 (2005).
14. Eiholzer U, Nordmann Y, l'Allemand D. Fatal outcome of sleep apnoea in PWS during the initial phase of growth hormone treatment. Horm. Res. 58(Suppl. 3), 24-26 (2002).
15. Nordmann Y, Eiholzer U, l'Allemand D, Mirjanic S, Markwalder C. Sudden death of an infant with Prader-Willi syndrome - notm a unique case? Biol. Neon. 82, 139-141 (2002).
16. Schrander-Stumpel C, Curfs L, Sastrowijoto P, Cassidy S, Schrander J, Fryns J. Prader-Willi Syndrome: causes of death in an international series of 27 cases. Am. J. Med. Genet. 124A, 333-338 (2004).
17. Whittington J, Holland A, Webb T, Butler J, Clarke D, Boer H. Population prevalence and estimated birth incidence and mortality rate for people with Prader Willi syndrome in one UK health Region. J. Med. Genet. 38, 792-798 (2001).
18. Eiholzer U, Gisin R, Weinmann C et al. Treatment with human growth hormone in patients with Prader-Labhart-Willi syndrome reduces body fat and increases muscle mass and physical performance. Eur. J. Pediatr. 157, 368-377 (1998).
19. Lindgren A, Hagenas L, Muller J et al. Growth hormone treatment of children with Prader-Willi syndrome affects linear growth and body composition favourably. Acta Paediatr. 87, 28-31 (1998).
20. Myers S, Carrel A, Whitman B, Allen B. Sustained benefit after 2 years of growth hormone on body composition, fat utilization, physical strength and agility, and growth in Prader-Willi syndrome. J. Pediatr. 137, 42-49 (2000).
21. Vliet G, Deal C, Crock P, Robitaille Y, Oligny L. Sudden death in growth hormone treated children with Prader-Willi Syndrome. J. Pediatr. 144, 129-131 (2004).
22. Marcus C. Sleep-disordered breathing in children. Am. J. Respir. Crit. Care Med. 164, 16-30 (2001).
23. Partinen M, Telakivi T. Epidemiology of obstructive sleep apnea syndrome. Sleep 15, S1-S4 (1992).
24. Redline S, Tishler P, Schluter M, Aylor J, Clark K, Graham G. Risk factors for sleep-disordered breathing in children. Associations with obesity, race and respiratory problems. Am. J. Respir. Crit. Care Med. 159, 1527-1532 (1999).
25. Eller Shelton K, Woodson H, Gay S, Suratt P. Pharyngeal fat in obstructive sleep apnea. Am. Rev. Respir. Dis. 148, 462-466 (1994).
26. Trang H. Sleep-disordered breathing in children with common obesity. In: Prader-Willi Syndrome as a Model for Obesity. Eiholzer U, l'Allemand D, Zipf W (Eds). Karger, Zurich, Germany, 119-127 (2003).
27. Burger C, Stanson A, Daniels B, Sheedy P, Shepard J. Fast-CT evaluation of the effect of lung volume on upper airway size and function in normal men. Am. Rev. Respir. Dis. 146, 335-339 (1992).
28. Harris J, Allen R. Is excessive daytime sleepiness characteristic of Prader-Willi Syndrome? The effects of weight change. Arch. Pediatr. Adolesc. Med. 150, 1288-1293 (1996).
29. Pavone M, Paglietti M, Petrone A, Crino A, De Vincentiis G, Cutrera R. Adenotonsillectomy for obstructive sleep apnea in children with Prader-Willi syndrome. Pediatr. Pulmonol. 41, 74-79 (2006).
30. Guilleminault C, Kurland G, Winkle R. Severe kyphoscoliosis, breathing and sleep: The "Quasimodo" syndrome during sleep. Chest 79, 626-630 (1981).
31. Nagai T, Obata K, Ogata T et al. Growth hormone therapy and scoliosis in patients with Prader-Willi syndrome. Am. J. Med. Genet. 140, 1623-1627 (2006).
32. Festen D, De Weerd A. van den Bossche R, Joosten K, Hoeve H, Hokken-Koelega A. Sleep-related breathing disorders in pre-pubertal children with Prader-Willi syndrome and effects of growth hormone treatment. J. Clin. Endocrinol. Metab. 91, 4911-4915 (2006).
33. Schluter B, Buschatz D, Trowitzsch E, Aksu F, Andler W. Respiratory control in children with Prader-Willi Syndrome. Eur. J. Pediatr. 156, 65-68 (1997).
34. Livingston F, Arens R, Bailey S, Keens T, Davidson Ward S. Hypercapnic arousal responses in Prader-Willi Syndrome. Chest 108, 1627-1631 (1995).
35. Vela-Bueno A, Kales A, Soldatos C et al. Sleep in the Prader Willi Syndrome. Clinical and polygraphic findings. Arch. Neurol. 41, 294-296 (1984).
36. Swaab D, Purba J, Holman M. Alterations in the hypothalamic paraventricular nucleus and its oxytocin neurons (putative satiety cells) in Prader-Willi syndrome. J. Clin. Endocrinol. Metab. 80, 573-579 (1995).
37. Mack S, Kc P, Wu M, Coleman B, Tolentino-Silva F, Haxhiu M. Paraventricular oxytocin neurons are involved in neural modulation of breathing. J. Appl. Physiol. 92, 826-834 (2002).
38. Ren J, Lee S, Pagliardini S et al. Absence of Ndn, encoding the Prader-Willi syndrome deleted gene necdin, results in congenital deficiency of central respiratory drive in neonatal mice. J. Neurosci. 23, 1569-1573 (2003).
39. MacDonald H, Wevrick R. The necdin gene is deleted in Prader-Willi syndrome and is imprinted in human and mouse. Hum. Mol. Genet. 6, 1873-1878 (1997).
40. Muscatelli F, Abrous D, Massacrier A et al. Disruption of the mouse Necdin gene results in hypothalamic and behavioral alterations reminiscent of the human Prader-Willi syndrome. Hum. Mol. Genet. 9, 3101-3110 (2000)
41. Arens R, Gozal D, Burrell B et al. Arousal and cardiorespiratory responses to hypoxia in Prader-Willi Syndrome. Am. J. Respir. Crit. Care Med. 153(1), 283-287 (1996).
42. Hertz G, Cataletto M, Feinsilver S, Angulo M. Developmental trends of sleep-disordered breathing in Prader-Willi Syndrome: the role of obesity. Am. J. Med. Genet. 56, 188-190 (1995).
43. Poulain M, Doucet M, Major G et al. The effect of obesity on chronic respiratory diseases: pathophysiology and therapeutic strategies. CMAJ 174, 1293-1299 (2006).
44. Mezon B, West P, Israels J. Sleep breathing abnormalities in kyphoscoliosis. Am. Rev. Respir. Dis. 122, 617-621 (1980).
45. Orenstein D, Boat F, Owens R et al. The obesity hypoventilation syndrome in children with Prader-Willi syndrome: a role for familial decreased response to carbon dioxide. J. Pediatr. 97, 765-767 (1980).
46. Gozal D, Arens R, Omlin K, Davidson Ward S, Keens T. Absent peripheral chemosensitivity in Prader-Willi syndrome. J. Appl. Physiol. 77, 2231-2236 (1994).
47. Arens R, Gozal D, Omlin K et al. Hypoxic and hypercapnic ventilatory responses in Prader-Willi syndrome. J. Appl. Physiol. 77 (5), 2224-2230 (1994).
48. Menendez A. Abnormal ventilatory responses in children with Prader-Willi Syndrome. Eur. J. Pediatr. 158, 941-942 (1999).
49. Dillon G, Waldrop T. Responses of feline caudal hypothalamic respiratory neurons to hypoxia and hypercapnia. Exp. Brain Res. 96, 260-272 (1993).
50. White D. Sleep apnea. Exp. Brain Res. 3, 124-128 (2006).
51. Laurance B, Brito A, Wilkinson J. Prader-Willi syndrome after 15 years. Arch. Dis. Child. 56, 181-186 (1981)
52. Hiroe Y, Inoue Y, Higami S, Suto Y, Kawahara R. Relationship between hypersomnia and respiratory disorder during sleep in Prader Willi syndrome. Psychiatry Clin. Neurosci. 54, 323-325 (2000).
53. Sforza E, Krieger J, Geisert J, Kurtz D. Sleep and breathing abnormalities in case of Prader-Willi syndrome. The effects of acute continuous positive airway pressure treatment. Acta Pediatr. Scand. 80, 80-85 (1991).
54. Chervin R, Ruzicka D, Giordani B et al. Sleep-disordered breathing, behavior, and cognition in children before and after adenotonsillectomy. Pediatrics 117, 769-777 (2006).
55. Gottlieb D, Chase C, Vezina R et al. Sleep-disordered breathing symptoms are associated with poorer cognitive function in 5-year-old children. J. Pediatr. 145, 458-464 (2004).
56. Gozal D. Sleep-disordered breathing and school performance in children. Pediatrics 102, 616-620 (1998).
57. O'Donoghue F, Camfferman D, Kennedy J et al. Sleep-disordered breathing in Prader-Willi syndrome and its associations with neurobehavioral abnormalities. J. Pediatr. 147, 823-829 (2005).
58. Beebe D, Gozal D. Obstructive sleep apnea and the prefrontal cortex: towards a comprehensive model linking nocturnal upper airway obstruction to daytime cognitive and behavioral deficits. J. Sleep Res. 11, 1-16 (2002).
59. Festen D, Wevers M, De Weerd A et al. Psychomotor development and associations with sleep-related breathing disorders in infants with Prader-Willi Syndrome. Ped. Res. (2007) (In press).
60. Eiholzer U, l'Allemand D, van der Sluis I, Steinert H, Gasser T, Ellis K. Body composition abnormalities in children with Prader-Willi syndrome and long-term effects of growth hormone therapy. Horm. Res. 53, 200-206 (2000).
61. Lindgren A, Ritzen E. Five years of growth hormone treatment in children with Prader-Willi syndrome. Acta Pediatr. 433(Suppl.), 109-111 (1999).
62. Whitman B, Myers S, Carrel A, Allen D. The behavioral impact of growth hormone treatment for children and adolescents with Prader-Willi Syndrome: a 2-year controlled study. Pediatrics 109, E35 (2002).
63. Hoybye C, Hilding A, Jacobsson H, Thoren M. Growth hormone-treatment improves body composition in adults with Prader-Willi Syndrome. Clin. Endocrinol. 58, 653-661 (2003).
64. Grunstein R, Ho K. Sullivan C. Sleep apnea in acromegaly. Ann. Int. Med. 115, 527-532 (1991)
65. Hermann B, Wessendorf T, Ajaj W. Kahlke S, Teschler H, Mann K. Effects of octreotide on sleep apnoea and tongue volume (magnetic resonance imaging) in patients with acromegaly, Eur. J. Endocrinol. 151, 309-315 (2004).
66. Gerard J, Garibaldi L, Myers S. Aceto TJ, Kotagal S, Gibbons V. Sleep apnea in patients receiving growth hormone. Clin. Pediatr. 36, 321-326 (1997).
67. Hansen T, Moller J, Thomsen K et al. Effects of growth hormone on renal tubular handling of sodium in healthy humans. Am. J. Physiol. Endocrinol. Metab., 281, E1326-E1332 (2001).
68. Haqq A, Stadler D, Jackson R, Rosenfeld R, Purrien J, LaFranchi S. Effects of growth hormone on pulmonary function, sleep quality, behavior, cognition, growth velocity body composition, and resting energy expenditure in Prader-Willi Syndrome. J. Clin. Endocrinol. Metab. 88, 2206-2212 (2003).
69. 2 response, ventilation and central inspiratory drive in children with Prader-Willi syndrome. Eur. J. Pediatr. 158, 936-940 (1999).
70. Miller J, Silverstein J, Shuster J, Driscoll D, Wagner M. Short-term effects of growth hormone on sleep abnormalities in Prader-Willi syndrome. J. Clin. Endocrinol. Metab. 91(2) 413-417 (2006).
71. Bady E, Achkar A, Pascal S, Orvoen-Frija E, Laaban J-P. Pulmonary arterial hypertension in patients with sleep apnoea syndrome. Thorax 55, 934-939 (2000).
72. Marcus C, Curtis S, Koerner C. Joffe A, Serwint J, Loughlin G. Evaluation of pulmonary function and polysomnography in obese children and adolescents. Pediatr. Pulmonol. 21, 176-183 (1996).
73. Smith I, King M, Siklos P, Shneerson J. Treatment of ventilatory failure in the Prader-Willi syndrome. Eur. Resp. J. 11, 1150-1152 (1998).
74. Hudgel D, Thanakitcharu S. Pharmacologic treatment of sleep-disordered breathing. Am. J. Respir. Crit. Care Med. 158, 691-699 (1998).